AngioScore develops, makes and sells leading edge tools for endovascular therapy.
Acquired by The Spectranetics Corporation in 2014.
Menu
Menu
AngioScore develops, makes and sells leading edge tools for endovascular therapy.
Acquired by The Spectranetics Corporation in 2014.
300 Montgomery Street
Suite 1130
San Francisco, CA 94104
